Disease and Health Research: Recent Developments Vol. 3

Foot ulceration remains the most common cause of hospitalisation and non-traumatic lower-limb amputation among people living with diabetes mellitus, and its five-year mortality approaches that of several common malignancies. Despite three decades of international guideline development and a large therapeutic literature, amputation rates have not fallen consistently, and inequalities in outcome appear to be widening. This critical narrative review examines the state of knowledge on the pathophysiology, assessment, management and prevention of diabetes-related foot ulceration, and asks why an apparently well-characterised causal pathway has proved so resistant to translation into reliable clinical benefit. Literature was identified through structured searching of PubMed, PubMed Central and Europe PMC, the Directory of Open Access Journals, Crossref, Semantic Scholar and Google Scholar, supplemented by backward and forward citation tracking and by examination of guideline evidence syntheses. Sources were appraised for design adequacy, risk of bias, outcome relevance, generalisability and consistency with the wider evidence, and were synthesised thematically rather than sequentially. Three findings dominate the appraisal. First, the classical triad of neuropathy, deformity and trauma is well supported for ulcer initiation, but the relative contribution of arterial disease, medial arterial calcification and microvascular dysfunction to non-healing remains poorly quantified, and mechanistic plausibility has repeatedly outrun demonstrated effectiveness. Second, the interventions with the most secure evidence are mechanical and organisational rather than biological, whereas the largest volume of trial activity concerns advanced wound products supported predominantly by small, industry-sponsored studies of low certainty. Third, prevention rests on a narrow evidential base in which only a few interventions reach moderate certainty, and screening has never satisfied established criteria for population-wide programmes. Heterogeneous outcome definitions, exclusion of ischaemic and infected ulcers from pivotal trials, and marked geographical concentration of research constrain confidence throughout. Priorities include pragmatic trials in unselected populations, standardised outcome reporting, and implementation research addressing the persistent gap between guideline recommendation and delivered care.